SIGMA LABS, INC.·4

Aug 13, 7:00 PM ET

Fisher Ronald Kenneth Jr 4

4 · SIGMA LABS, INC. · Filed Aug 13, 2021

Insider Transaction Report

Form 4
Period: 2021-08-11
Fisher Ronald Kenneth Jr
Vice President of Business Dev
Transactions
  • Award

    Stock Option (right to buy)

    2021-08-11+30,31330,313 total
    Exercise: $3.42Exp: 2026-08-11Common Stock (30,313 underlying)
  • Award

    Stock Appreciation Right

    2021-08-11+30,31330,313 total
    Exercise: $3.42Exp: 2026-08-11Common Stock (30,313 underlying)
Footnotes (2)
  • [F1]The stock option will vest and become exercisable as follows: (i) 25% of the option vested on the grant date (i.e., August 11, 2021), and (ii) the balance of the option will vest in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.
  • [F2]The stock appreciation right ("SAR") is payable in cash only, and vests as follows: (i) 25% of the SAR vested on the grant date (i.e., August 11, 2021), and (ii) the balance of the SAR will vest in equal (as closely as possible) monthly installments over three years from the grant date, subject, in each case, to the Reporting Person being in the continuous employ of the Issuer on the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary